Peptides for Longevity: Evaluating Healthy-Aging Claims
VA Health & Wellness2 min read
In short
No evidence reviewed here establishes that the wellness peptides in the catalog extend human life or reverse aging. Longevity claims often move from laboratory mechanisms to conclusions that have not been demonstrated in patients. Healthy-aging decisions should focus on measurable function, medical needs, preventive care, and realistic expectations.
On this page
Key takeaways
- What does longevity mean in an advertisement?
The word may refer to lifespan, day-to-day energy, skin appearance, or a laboratory measurement.
- Why are laboratory mechanisms insufficient?
A pathway related to aging can be relevant to research without providing a validated treatment.
- What should you know about Epithalon?
Epithalon is also commonly called epitalon.
- What about NAD+?
A 2026 retrospective NAD+ infusion study examined tolerability and short-term markers in a commercial setting.
- Which goals are more practical?
NIH's healthy-aging resources emphasize areas such as activity, nutrition, medical care, and mental health.
- Choose questions that lead to useful care
Use our research-reading guide and dedicated Epithalon article before discussing a longevity product.
What does longevity mean in an advertisement?
The word may refer to lifespan, day-to-day energy, skin appearance, or a laboratory measurement. Those outcomes are not interchangeable. Ask the provider to name the intended benefit in concrete terms. A claim about feeling more energetic is not proof of living longer, and a molecular change is not proof of fewer illnesses. The clearer the outcome, the easier it is to evaluate the supporting evidence.
Why are laboratory mechanisms insufficient?
A pathway related to aging can be relevant to research without providing a validated treatment. Look for studies that actually administered the proposed product to people and measured the outcome being advertised. Consider how long the participants were followed. Evidence from cells or animals, or from short human biomarker studies, should retain those limitations when translated into patient education.
What should you know about Epithalon?
Epithalon is also commonly called epitalon. FDA's assessment distinguishes it from the different preparation epithalamin and describes substantial gaps in effectiveness and safety evidence. [S14] (opens in a new tab) Avoid transferring findings between similarly named products. A headline about longevity can become misleading if the underlying research used a different substance, a different route, or an outcome unrelated to human lifespan.
What about NAD+?
A 2026 retrospective NAD+ infusion study examined tolerability and short-term markers in a commercial setting. [S24] (opens in a new tab) It did not establish that injections reverse aging. The design, route, and follow-up are essential parts of the result. Ask which research applies to the exact preparation under discussion, rather than accepting a general argument that an important cellular molecule must make a useful longevity treatment.
Which goals are more practical?
NIH's healthy-aging resources emphasize areas such as activity, nutrition, medical care, and mental health. [S29] (opens in a new tab) Instead of buying a broad anti-aging promise, identify the issue that most affects your life. It might be difficulty maintaining activity, a persistent sleep problem, or an overdue health assessment. Discuss the issue directly and ask what options have evidence relevant to it. Priorities can change as your circumstances change.
Choose questions that lead to useful care
Use our research-reading guide and dedicated Epithalon article before discussing a longevity product. VA Health & Wellness patients can ask for clear distinctions between hypotheses and established findings. This article provides education and does not endorse any peptide as a lifespan-extension or age-reversal therapy.
Frequently asked questions
Sources
[S24] Reyna et al., Frontiers in Aging: IV NAD+ versus nicotinamide riboside: retrospective tolerability pilot (opens in a new tab)
[S29] National Institute on Aging, NIH: What do we know about healthy aging? (opens in a new tab)
Related reading
Epithalon and Epitalon: Evidence Behind Longevity Claims
October 29, 2026 · 2 min read
NAD+ Injections: Human Evidence, Safety, and Expectations
How to Read Peptide Research Without Overstating the Results
October 13, 2026 · 2 min read